These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 198661)
1. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone. Metz SA; Baylink DJ; Hughes MR; Haussler MR; Robertson RP N Engl J Med; 1977 Nov; 297(20):1084-90. PubMed ID: 198661 [TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395 [TBL] [Abstract][Full Text] [Related]
3. Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects. Bilezikian JP; Canfield RE; Jacobs TP; Polay JS; D'Adamo AP; Eisman JA; DeLuca HF N Engl J Med; 1978 Aug; 299(9):437-41. PubMed ID: 210383 [TBL] [Abstract][Full Text] [Related]
4. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration. Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718 [TBL] [Abstract][Full Text] [Related]
5. Resistance to vitamin D and parathyroid hormone. Moses AM N Engl J Med; 1978 Aug; 299(8):423-4. PubMed ID: 209328 [No Abstract] [Full Text] [Related]
6. Hereditary hypophosphatemic rickets with hypercalciuria. Tieder M; Modai D; Samuel R; Arie R; Halabe A; Bab I; Gabizon D; Liberman UA N Engl J Med; 1985 Mar; 312(10):611-7. PubMed ID: 2983203 [TBL] [Abstract][Full Text] [Related]
7. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism. Aksnes L; Aarskog D J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001 [TBL] [Abstract][Full Text] [Related]
8. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3. Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630 [TBL] [Abstract][Full Text] [Related]
9. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone. Connors MH; Irias JJ; Golabi M Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477 [TBL] [Abstract][Full Text] [Related]
10. Effect of phenytoin on bone and vitamin D metabolism. Bell RD; Pak CY; Zerwekh J; Barilla DE; Vasko M Ann Neurol; 1979 Apr; 5(4):374-8. PubMed ID: 220903 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster. Knox FG; Preiss J; Kim JK; Dousa TP J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function. Suh SM; Tashjian AH; Matsuo N; Parkinson DK; Fraser D J Clin Invest; 1973 Jan; 52(1):153-60. PubMed ID: 4345201 [TBL] [Abstract][Full Text] [Related]
13. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763 [TBL] [Abstract][Full Text] [Related]
14. Lack of response of 1,25-dihydroxycholecalciferol to exogenous parathyroid hormone in a patient with treated pseudohypoparathyroidism. Braun JJ; Birkenhäger JC; Visser TJ; Juttmann JR Clin Endocrinol (Oxf); 1981 Apr; 14(4):403-7. PubMed ID: 6266703 [TBL] [Abstract][Full Text] [Related]
15. Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. Chertow BS; Baylink DJ; Wergedal JE; Su MH; Norman AW J Clin Invest; 1975 Sep; 56(3):668-78. PubMed ID: 1159080 [TBL] [Abstract][Full Text] [Related]
16. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3. Massry SG; Tuma S; Dua S; Goldstein DA J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism. Lambert PW; Hollis BW; Bell NH; Epstein S J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719 [TBL] [Abstract][Full Text] [Related]
18. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone. Fujita T; Nomura M; Okajima S; Furuya H J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136 [TBL] [Abstract][Full Text] [Related]
19. [Kidney and osseous responsiveness to PTH in a case of pseudohypoparathyroidism (author's transl)]. Quesada JM; Guerrero J; Hervás F; Vázquez C An Esp Pediatr; 1981 Mar; 14(3):183-8. PubMed ID: 6267973 [TBL] [Abstract][Full Text] [Related]
20. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. Stewart AF; Adler M; Byers CM; Segre GV; Broadus AE N Engl J Med; 1982 May; 306(19):1136-40. PubMed ID: 6280047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]